NCT06997016
Enhanced Recovery After Surgery (ERAS) in Live Donor Kidney Transplant Recipients
Enrolling by Invitation
PHASE4Ages 18+InterventionalTreatmentBaylor Research InstituteInvestigator-initiated
~60 participants
Updated 2026-01-27 on ClinicalTrials.gov
What's tested:pre-operative carbohydrate drinkAcetaminophenGabapentinBupivacaineAmbulation
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Numerical Rating Scale (NRS) (0-10)
Measured over From enrollment to the end of treatment at 30 days
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesTexas1
Study leadership
- Richard Ruiz, MD · PRINCIPAL_INVESTIGATOR · Baylor Scott & White All Saints Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Adult patients
over 18 years of age
receiving a kidney transplant from a living donor.
Exclusion
delayed gastric emptying
severe type I diabetes
allergy to interventional medications
pregnancy (this is a normal exclusion for kidney recipients)
What this trial measures
- Numerical Rating Scale (NRS) (0-10)From enrollment to the end of treatment at 30 days
Patient reported pain on a scale from 0 (no pain) to 10 (the worst possible pain)
- Narcotic UseFrom enrollment to the end of treatment at 30 days
milligram morphine equivalents (MME)